All In Biotech

Investigational drug · Phase 3

Saroglitazar Magnesium

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Fibrosis.

Phase 3

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

5

3 still active

All registered trials

18

Any phase or sponsor naming "Saroglitazar Magnesium"

First trial start

2021

Aug 18, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Saroglitazar Magnesium", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Primary Biliary Cholangitis
  • Nonalcoholic Steatohepatitis
  • Fibrosis

Approved drugs for the same conditions: MASH (fatty liver disease) · Primary biliary cholangitis · Infectious disease and vaccines · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "Saroglitazar Magnesium" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 11 on PubMed

Also in development for Primary Biliary Cholangitis

  • VolixibatSHP626Phase 22 trials

    Mirum Pharmaceuticals, Inc. · Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, PBC

  • CNP-104Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Primary Biliary Cholangitis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.